Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - MEDASSETS INCa50363004ex99-1.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported):

August 1, 2012

 

MedAssets, Inc.

 
(Exact name of registrant as specified in its charter)


Delaware

 

001-33881

 

51-0391128

 

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)


100 North Point Center E, Suite 200,

Alpharetta, Georgia

 

30022

 

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code:

678-323-2500

  Not Applicable
 
(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 2.02 Results of Operations and Financial Condition.

On August 1, 2012, MedAssets, Inc. (the "Company") issued a press release describing financial results of the Company for the second quarter ended June 30, 2012.  A copy of the press release is attached as Exhibit 99.1 and is being incorporated herein by reference.

The Item 2.02 of this Form 8-K and the information incorporated by reference herein, including Exhibit 99.1 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit

Number

 

Description

 
99.1 Press Release, dated August 1, 2012.
 
 
This exhibit is furnished pursuant to Item 2.02 and shall not be deemed to be “filed.”


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MedAssets, Inc.
 
 

August 1, 2012

By:

/s/ Charles O. Garner

Name: Charles O. Garner

 

Title: Executive Vice President and Chief Financial Officer


EXHIBIT INDEX


Exhibit No.

Description

 

99.1

Press release dated August 1, 2012.